Literature DB >> 16272468

Molecular evolution of methicillin-resistant Staphylococcus aureus in the metropolitan area of Cologne, Germany, from 1984 to 1998.

Hilmar Wisplinghoff1, Birgitta Ewertz, Susanne Wisplinghoff, Danuta Stefanik, Georg Plum, Francoise Perdreau-Remington, Harald Seifert.   

Abstract

To investigate the molecular evolution of methicillin-resistant Staphylococcus aureus (MRSA) in a large metropolitan area in Germany, 398 nonrepetitive MRSA isolates recovered from patients from various teaching and nonteaching hospitals in Cologne between 1984 and 1998 were characterized by pulsed-field gel electrophoresis (PFGE). On this basis, 95 representative isolates were selected and further investigated by multilocus sequence typing (MLST), spa typing, and staphylococcal cassette chromosome mec (SCCmec) typing. Overall, there were 9 MLST types and 16 spa types. The most prevalent sequence types (STs) were ST239 (38% of isolates), ST247 (29%), and ST228 (18%); the most prevalent spa types were 37 (32%) and 51 (29%). ST239 comprised five major PFGE types and various unique PFGE patterns, and ST5 comprised two PFGE types. While the same PFGE pattern was not observed among strains with different STs, spa type 37 was observed among strains representing two different STs (ST239 and ST241), and these belonged to the same clonal complex as single-locus variants. ST239 was the earliest predominant ST, with the highest prevalence from 1984 to 1988 (96%), followed by ST247 from 1989 to 1993 (83%) and ST228 from 1994 to 1998 (40%). Spa type 37 was the most prevalent from 1984 to 1988 (96%), spa type 51 was the most prevalent from 1989 to 1993 (83%), and spa types 1 and 458 were the most prevalent from 1994 to 1998 (26% and 14%, respectively). The prevalence of SCCmec type III decreased from 96% from 1984 to 1988 to 8% from 1989 to 1993, the prevalence of SCCmec type I increased from 4% from 1984 to 1988 to 97% from 1989 to 1993 and decreased to 62% from 1994 to 1998. While the genetic diversity of MRSA increased from 1984 to 1998, one prevalent ST usually accounted for most of the isolates in a given time period.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16272468      PMCID: PMC1287791          DOI: 10.1128/JCM.43.11.5445-5451.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  48 in total

Review 1.  Antibiotic resistance in gram-positive bacteria: epidemiological aspects.

Authors:  W Witte
Journal:  J Antimicrob Chemother       Date:  1999-09       Impact factor: 5.790

Review 2.  Multilocus sequence typing: molecular typing of bacterial pathogens in an era of rapid DNA sequencing and the internet.

Authors:  B G Spratt
Journal:  Curr Opin Microbiol       Date:  1999-06       Impact factor: 7.934

3.  The first Staphylococcus aureus isolates with reduced susceptibility to vancomycin in Poland.

Authors:  Jolanta Krzysztoń-Russjan; Marek Gniadkowski; Hanna Połowniak-Pracka; Elzbieta Hagmajer; Waleria Hryniewicz
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

4.  Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management.

Authors:  Dag Harmsen; Heike Claus; Wolfgang Witte; Jörg Rothgänger; Hermann Claus; Doris Turnwald; Ulrich Vogel
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

5.  Evolution of Staphylococcus aureus by large chromosomal replacements.

Authors:  D Ashley Robinson; Mark C Enright
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

6.  Evolution of sporadic isolates of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and their similarities to isolates of community-acquired MRSA.

Authors:  M Aires de Sousa; H de Lencastre
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

7.  Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains.

Authors:  B Shopsin; M Gomez; S O Montgomery; D H Smith; M Waddington; D E Dodge; D A Bost; M Riehman; S Naidich; B N Kreiswirth
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

8.  Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus.

Authors:  D Ashley Robinson; Mark C Enright
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

Review 9.  Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus.

Authors:  D A Robinson; M C Enright
Journal:  Clin Microbiol Infect       Date:  2004-02       Impact factor: 8.067

10.  Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database.

Authors:  Linda K McDougal; Christine D Steward; George E Killgore; Jasmine M Chaitram; Sigrid K McAllister; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

View more
  16 in total

1.  Longitudinal study of the molecular epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital.

Authors:  Sabine Petersdorf; Klaus Oberdorfer; Constanze Wendt
Journal:  J Clin Microbiol       Date:  2006-10-04       Impact factor: 5.948

2.  Evaluation of quantitative antibiotic susceptibility testing by Vitek 2 as a routine method to predict strain relatedness of coagulase-negative staphylococci isolated from blood cultures.

Authors:  Antonia Camerer; Anke Kohlenberg; Danuta Stefanik; Harald Seifert
Journal:  J Clin Microbiol       Date:  2011-07-27       Impact factor: 5.948

3.  First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia.

Authors:  S Al-Obeid; Q Haddad; A Cherkaoui; J Schrenzel; P François
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

4.  Thermal shock susceptibility and regrowth of Pseudomonas aeruginosa biofilms.

Authors:  Erica B Ricker; Haydar A S Aljaafari; Trigg M Bader; Bryce S Hundley; Eric Nuxoll
Journal:  Int J Hyperthermia       Date:  2018-03       Impact factor: 3.914

5.  Molecular characterization of methicillin-resistant Staphylococcus aureus isolates in Korea.

Authors:  Eu Suk Kim; Hye Jin Lee; Gyung-Tae Chung; Yeong-Seon Lee; Dong-Hyeon Shin; Sook-In Jung; Kyoung-Ho Song; Wan-Beom Park; Nam Joong Kim; Kyoung Un Park; Eui-Chong Kim; Myoung-Don Oh; Hong Bin Kim
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

6.  Molecular characterization of resistance to Rifampicin in an emerging hospital-associated Methicillin-resistant Staphylococcus aureus clone ST228, Spain.

Authors:  Virginie Mick; M Angeles Domínguez; Fe Tubau; Josefina Liñares; Miquel Pujol; Rogelio Martín
Journal:  BMC Microbiol       Date:  2010-03-04       Impact factor: 3.605

7.  Clonality of epidemic methicillin-resistant Staphylococcus aureus strains in Finland as defined by several molecular methods.

Authors:  A Vainio; M Kardén-Lilja; S Ibrahem; A M Kerttula; S Salmenlinna; A Virolainen; J Vuopio-Varkila
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-15       Impact factor: 3.267

8.  Countrywide molecular survey of methicillin-resistant Staphylococcus aureus strains in Poland.

Authors:  Agnieszka Łuczak-Kadłubowska; Agnieszka Sulikowska; Joanna Empel; Anna Piasecka; Monika Orczykowska; Aleksandra Kozinska; Waleria Hryniewicz
Journal:  J Clin Microbiol       Date:  2008-07-09       Impact factor: 5.948

9.  Population structure of a hybrid clonal group of methicillin-resistant Staphylococcus aureus, ST239-MRSA-III.

Authors:  Davida S Smyth; Linda K McDougal; Frode W Gran; Anand Manoharan; Mark C Enright; Jae-Hoon Song; Herminia de Lencastre; D Ashley Robinson
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

10.  Staphylococcal cassette chromosome mec in MRSA, Taiwan.

Authors:  Jann-Tay Wang; Chi-Tai Fang; Yee-Chun Chen; Chia-Ling Wu; Mei-Ling Chen; Shan-Chwen Chang
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.